Journal of Clinical Endocrinology & Metabolism, Vol 72, 1001-1007, Copyright © 1991 by Endocrine Society

ARTICLES

The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation

SC Riley, JC Walton, JM Herlick and JR Challis
Department of Obstetrics and Gynecology, Lawson Research Institute, University of Western Ontario, St. Joseph's Health Centre, London, Canada.

Using immunohistochemical techniques, we have determined the localization and distribution of CRH immunoreactivity (CRH-IR) in the human placenta, fetal membranes, decidua, and umbilical cord. Tissues were obtained at 6-8 weeks of pregnancy, at term, in association with premature birth, and from patients with pregnancy-induced hypertension or diabetes mellitus. A polyclonal antibody to the epithelial cell marker cytokeratin was used to identify trophoblast cells. CRH-IR was not detected in placenta or decidua at 6-8 weeks gestation. In tissues obtained after idiopathic premature delivery after 21 weeks gestation, positive CRH staining was found in placenta in syncytiotrophoblast and intermediate trophoblast, but not cytotrophoblast. CRH-IR was present in intermediate trophoblast cells that had invaded maternal blood vessels in decidua basalis. In the fetal membranes, CRH-IR was localized in the epithelium and subepithelial cells of amnion, in the trophoblast layer, in some cells of the reticular and cellular layers of chorion, and in some stromal cells and invasive trophoblast cells of decidua. CRH-IR was found in the amniotic epithelium of the umbilical cord and in the musculature of the umbilical vessels. This pattern of distribution of CRH-IR was found in tissues from 21 weeks gestation to term and postterm, and was similar in tissues examined from patients with pregnancy-induced hypertension and diabetes mellitus. These results show clearly that in placenta and membranes, CRH is localized primarily to syncytiotrophoblast and intermediate trophoblast, but not to cytotrophoblast cells. We suggest that the localization of CRH-IR is consistent with CRH affecting paracrine/autocrine interactions within the placenta, fetal membranes, and decidua that may be involved in the maturation of the fetal hypothalamic-pituitary-adrenal axis and in the stimulus and maintainance of labor.

This article has been cited by other articles:

				Yue Hou, Xiaolu Tang, R. C. Nicholson, and Xin Ni Phorbol Ester Stimulates Corticotropin-Releasing Hormone Gene Promoter Activity Through a cAMP Regulatory Element in Primary Placental Cells Reproductive Sciences, January 1, 2008; 15(1): 33 - 39. [Abstract] [PDF]

				L. Gao, P. He, J. Sha, C. Liu, L. Dai, N. Hui, and X. Ni Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 Mediate Differential Effects on 15-Hydroxy Prostaglandin Dehydrogenase Expression in Cultured Human Chorion Trophoblasts Endocrinology, August 1, 2007; 148(8): 3645 - 3654. [Abstract] [Full Text] [PDF]

				R. Yang, X. You, X. Tang, L. Gao, and X. Ni Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts J. Mol. Endocrinol., December 1, 2006; 37(3): 533 - 540. [Abstract] [Full Text] [PDF]

				G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF]

				W. Li and J. R. G. Challis Corticotropin-Releasing Hormone and Urocortin Induce Secretion of Matrix Metalloproteinase-9 (MMP-9) without Change in Tissue Inhibitors of MMP-1 by Cultured Cells from Human Placenta and Fetal Membranes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6569 - 6574. [Abstract] [Full Text] [PDF]

				M.-J. Lee, Z. Wang, H. Yee, Y. Ma, N. Swenson, L. Yang, S. S. Kadner, R. N. Baergen, S. K. Logan, M. J. Garabedian, et al. Expression and Regulation of Glucocorticoid Receptor in Human Placental Villous Fibroblasts Endocrinology, November 1, 2005; 146(11): 4619 - 4626. [Abstract] [Full Text] [PDF]

				T. Teli, D. Markovic, M. A. Levine, E. W. Hillhouse, and D. K. Grammatopoulos Regulation of Corticotropin-Releasing Hormone Receptor Type 1{alpha} Signaling: Structural Determinants for G Protein-Coupled Receptor Kinase-Mediated Phosphorylation and Agonist-Mediated Desensitization Mol. Endocrinol., February 1, 2005; 19(2): 474 - 490. [Abstract] [Full Text] [PDF]

				E. Karteris, E. W. Hillhouse, and D. Grammatopoulos Urocortin II Is Expressed in Human Pregnant Myometrial Cells and Regulates Myosin Light Chain Phosphorylation: Potential Role of the Type-2 Corticotropin-Releasing Hormone Receptor in the Control of Myometrial Contractility Endocrinology, February 1, 2004; 145(2): 890 - 900. [Abstract] [Full Text] [PDF]

				K. J. McKeown and J. R. G. Challis Regulation of 15-Hydroxy Prostaglandin Dehydrogenase by Corticotrophin-Releasing Hormone through a Calcium-Dependent Pathway in Human Chorion Trophoblast Cells J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1737 - 1741. [Abstract] [Full Text] [PDF]

				H. Umezaki, D. L. Hess, G. J. Valenzuela, and C. A. Ducsay Fetectomy Alters Maternal Pituitary-Adrenal Function in Pregnant Rhesus Macaques Biol Reprod, November 1, 2001; 65(5): 1616 - 1621. [Abstract] [Full Text] [PDF]

				K. Erickson, P. Thorsen, G. Chrousos, D. E. Grigoriadis, O. Khongsaly, J. McGregor, and J. Schulkin Preterm Birth: Associated Neuroendocrine, Medical, and Behavioral Risk Factors J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2544 - 2552. [Abstract] [Full Text] [PDF]

				L. H. Allen Biological Mechanisms That Might Underlie Iron's Effects on Fetal Growth and Preterm Birth J. Nutr., February 1, 2001; 131(2): 581S - 589. [Abstract] [Full Text]

				J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye Endocrine and Paracrine Regulation of Birth at Term and Preterm Endocr. Rev., October 1, 2000; 21(5): 514 - 550. [Abstract] [Full Text]

				J. Robidoux, L. Simoneau, A. Masse, and J. Lafond Activation of L-Type Calcium Channels Induces Corticotropin-Releasing Factor Secretion from Human Placental Trophoblasts J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3356 - 3364. [Abstract] [Full Text]

				J. Robidoux, L. Simoneau, S. St-Pierre, A. Masse, and J. Lafond Characterization of Neuropeptide Y-Mediated Corticotropin-Releasing Factor Synthesis and Release from Human Placental Trophoblasts Endocrinology, August 1, 2000; 141(8): 2795 - 2804. [Abstract] [Full Text] [PDF]

				V. Jain, M. Longo, M. Ali, G. R. Saade, K. Chwalisz, and R. E. Garfield Expression of Receptors for Corticotropin-Releasing Factor in the Vasculature of Pregnant Rats Reproductive Sciences, May 1, 2000; 7(3): 153 - 160. [Abstract] [PDF]

				F. M. Reis, M. Fadalti, P. Florio, and F. Petraglia Putative Role of Placental Corticotropin-Releasing Factor in the Mechanisms of Human Parturition Reproductive Sciences, May 1, 1999; 6(3): 109 - 119. [Abstract] [PDF]

				V. Jain, Y. P. Vedernikov, G. R. Saade, K. Chwalisz, and R. E. Garfield Endothelium-Dependent and -Independent Mechanisms of Vasorelaxation by Corticotropin-Releasing Factor in Pregnant Rat Uterine Artery J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 407 - 413. [Abstract] [Full Text]

				I. M. Leitch, A. L. A. Boura, C. Botti, M. A. Read, W. A. W. Walters, and R. Smith Vasodilator Actions of Urocortin and Related Peptides in the Human Perfused Placenta in Vitro J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4510 - 4513. [Abstract] [Full Text]

				M. Y. Stevens, J. R. G. Challis, and S. J. Lye Corticotropin-Releasing Hormone Receptor Subtype 1 Is Significantly Up-Regulated at the Time of Labor in the Human Myometrium J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4107 - 4115. [Abstract] [Full Text]

				V. L. Clifton, J. F. Telfer, A. J. Thompson, I. T. Cameron, T. G. Teoh, S. J. Lye, and J. R. G. Challis Corticotropin-Releasing Hormone and Proopiomelanocortin-Derived Peptides Are Present in Human Myometrium J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3716 - 3721. [Abstract] [Full Text]

				T. M. Jeffray, S. G. Matthews, G. L. Hammond, and J. R. G. Challis Divergent changes in plasma ACTH and pituitary POMC mRNA after cortisol administration to late-gestation ovine fetus Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E417 - E425. [Abstract] [Full Text] [PDF]

				J. Robidoux, L. Simoneau, S. St-Pierre, H. Ech-Chadli, and J. Lafond Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E502 - E509. [Abstract] [Full Text] [PDF]

				X. Ni, E.-C. Chan, J. T. Fitter, and R. Smith Nitric Oxide Inhibits Corticotropin-Releasing Hormone Exocytosis But Not Synthesis by Cultured Human Trophoblasts J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4171 - 4175. [Abstract] [Full Text] [PDF]

				S. Mesiano and R. B. Jaffe Developmental and Functional Biology of the Primate Fetal Adrenal Cortex Endocr. Rev., June 1, 1997; 18(3): 378 - 403. [Abstract] [Full Text]

				P. Florio, R. J. Woods, A. R. Genazzani, P. J. Lowry, and F. Petraglia Changes in Amniotic Fluid Immunoreactive Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Levels in Pregnant Women at Term and during Labor J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 835 - 838. [Abstract] [Full Text] [PDF]

				K. Sun, K. Yang, and J. R. G. Challis Differential Expression of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Human Placenta and Fetal Membranes J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 300 - 305. [Abstract] [Full Text] [PDF]